Erythropoietin (EPO) Biomarkers Market: Transforming Precision Diagnosis and Anemia Management
The global healthcare industry is rapidly embracing precision medicine, where biomarkers play an increasingly important role in improving disease diagnosis, treatment selection, and patient monitoring. Among these, Erythropoietin (EPO) biomarkers have become valuable tools for evaluating anemia, chronic kidney disease (CKD), oncology-related conditions, and therapeutic response to...
0 Kommentare 0 Geteilt 170 Ansichten 0 Bewertungen
Gesponsert